ExonanoRNA focuses on developing first-in-class, RNA nanotechnology-based therapeutics for cancer treatment. ExonanoRNA is the leader in RNA nanotechnology. Based on the pioneering work of Dr. Peixuan Guo’s research on RNA nanotechnology for 20+ years, it has shown to overcome the limitations of conventional cancer therapeutics and can deliver its own therapeutics (siRNA, miRNA and chemical drugs) to specific cancer cells with significantly enhanced effect without any detectable toxicity or side effect.
Following our mission of “developing safe and personalized therapeutics for patients with cancer and infectious diseases,” ExonanoRNA spearheads the translation of RNA nanotechnology from research to clinic through the continuing development of our Pharmaceutical and Life Science Technology business.
ExonanoRNA is committed to supplying high-quality oligonucleotides for use in research, therapeutic, and diagnostic applications at competitive prices. We specialize in the production of oligonucleotides with challenging modifications and offer quantities ranging from .2umol to 1mmol. Our oligonucleotides can be purified as requested, whether that be standard desalting, anion-exchange HPLC, ion-paired reversed phase HPLC, or PAGE purification. All oligonucleotides are deprotected and shipped ready to use. Most orders can be shipped within weeks of order placement.
We specialize in the design and production of RNA nanoparticles.
ExonanoRNA has not received any reviews.
ExonanoRNA has not received any endorsements.